Respiratory Syncytial Virus (RSV) Protection Extended to April 30

Public Health Recommendations

The California Department of Public Health recommends continuing RSV immunization with RSV antibody products for another month, through April 30, 2026, to:

  • All infants aged 0 through 7 months, within 1 week of birth, ideally during the birth hospitalization or as soon as possible after discharge (unless prenatal RSV immunization occurred between 32 through 36 weeks of gestation and at least 14 days before delivery)
    • Nirsevimab or clesrovimab are recommended
  • Children aged 8 through 19 months at high risk of severe RSV
    • Only nirsevimab is recommended

Learn more. 

Stay connected to the City of Pasadena! Visit us online at CityOfPasadena.net; follow us on X, Instagram and Facebook; or call the City Service Center Monday through Friday during business hours at (626) 744-7311.